BACKGROUND: A high-sodium diet has little short-term effect on blood pressure in nonhypertensive individuals but, for unclear reasons, is associated with hypertension if consumed long term. We hypothesized that a chronically high sodium intake would be associated with increases in biomarkers of endothelial dysfunction, specifically serum uric acid (SUA) and urine albumin excretion (UAE), and that high sodium intake would be associated with incident hypertension among those with higher SUA and UAE. METHODS AND RESULTS: We prospectively analyzed the associations between sodium intake and the change in SUA (n=4062) and UAE (n=4146) among participants of the Prevention of Renal and Vascular End Stage Disease (PREVEND) study who were not taking antihypertensive medications. We also examined the association of sodium intake with the incidence of hypertension (n=5556) among nonhypertensive participants. After adjustment for confounders, each 1-g-higher sodium intake was associated with a 1.2-μmol/L increase in SUA (P=0.01) and a 4.6-mg/d increase in UAE (P<0.001). The relation between sodium intake and incident hypertension varied according to SUA and UAE. For each 1-g-higher sodium intake, the adjusted hazard ratio for developing hypertension was 0.98 (95% confidence interval, 0.89-1.08) among those in the lowest tertile of SUA and 1.09 (1.02-1.16) among those in the highest tertile. Corresponding hazard ratios were 0.99 (confidence interval, 0.93-1.06) among participants whose UAE was <10 mg/d and 1.18 (confidence interval, 1.07-1.29) among those whose UAE was >15 mg/d. CONCLUSIONS: Over time, higher sodium intake is associated with increases in SUA and UAE. Among individuals with higher SUA and urine UAE, a higher sodium intake is an independent risk factor for developing hypertension.
BACKGROUND: A high-sodium diet has little short-term effect on blood pressure in nonhypertensive individuals but, for unclear reasons, is associated with hypertension if consumed long term. We hypothesized that a chronically high sodium intake would be associated with increases in biomarkers of endothelial dysfunction, specifically serum uric acid (SUA) and urine albumin excretion (UAE), and that high sodium intake would be associated with incident hypertension among those with higher SUA and UAE. METHODS AND RESULTS: We prospectively analyzed the associations between sodium intake and the change in SUA (n=4062) and UAE (n=4146) among participants of the Prevention of Renal and Vascular End Stage Disease (PREVEND) study who were not taking antihypertensive medications. We also examined the association of sodium intake with the incidence of hypertension (n=5556) among nonhypertensive participants. After adjustment for confounders, each 1-g-higher sodium intake was associated with a 1.2-μmol/L increase in SUA (P=0.01) and a 4.6-mg/d increase in UAE (P<0.001). The relation between sodium intake and incident hypertension varied according to SUA and UAE. For each 1-g-higher sodium intake, the adjusted hazard ratio for developing hypertension was 0.98 (95% confidence interval, 0.89-1.08) among those in the lowest tertile of SUA and 1.09 (1.02-1.16) among those in the highest tertile. Corresponding hazard ratios were 0.99 (confidence interval, 0.93-1.06) among participants whose UAE was <10 mg/d and 1.18 (confidence interval, 1.07-1.29) among those whose UAE was >15 mg/d. CONCLUSIONS: Over time, higher sodium intake is associated with increases in SUA and UAE. Among individuals with higher SUA and urine UAE, a higher sodium intake is an independent risk factor for developing hypertension.
Authors: Feng J He; Maciej Marciniak; Nirmala D Markandu; Tarek F Antonios; Graham A MacGregor Journal: Hypertension Date: 2010-06-28 Impact factor: 10.190
Authors: Coen D A Stehouwer; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter Journal: Kidney Int Suppl Date: 2004-11 Impact factor: 10.545
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Luigi X Cubeddu; Irene S Hoffmann; Lisette M Aponte; Rosaura Nuñez-Bogesits; Helimenia Medina-Suniaga; Magaly Roa; Robert S Garcia Journal: Am J Hypertens Date: 2003-05 Impact factor: 2.689
Authors: Mads Damkjær; Gustaf L Isaksson; Jane Stubbe; Boye L Jensen; Kasper Assersen; Peter Bie Journal: Pflugers Arch Date: 2012-10-25 Impact factor: 3.657
Authors: Lauren D Reschke; Edgar R Miller; Jeffrey J Fadrowski; Lauren F Loeffler; Kathryn W Holmes; Lawrence J Appel; Tammy M Brady Journal: Pediatr Nephrol Date: 2015-07-02 Impact factor: 3.714
Authors: Charlotte A Keyzer; Hiddo J Lambers-Heerspink; Michel M Joosten; Petronella E Deetman; Ron T Gansevoort; Gerjan Navis; Ido P Kema; Dick de Zeeuw; Stephan J L Bakker; Martin H de Borst Journal: Clin J Am Soc Nephrol Date: 2015-10-08 Impact factor: 8.237